| Primary |
| Product Used For Unknown Indication |
42.3% |
| Osteoporosis |
28.5% |
| Drug Use For Unknown Indication |
6.8% |
| Osteoporosis Prophylaxis |
4.3% |
| Rheumatoid Arthritis |
3.9% |
| Osteoporotic Fracture |
2.1% |
| Osteopenia |
1.9% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Hypertension |
1.0% |
| Prophylaxis |
1.0% |
| Osteoarthritis |
0.9% |
| Renal Transplant |
0.9% |
| Breast Cancer |
0.8% |
| Asthma |
0.7% |
| Pemphigus |
0.7% |
| Temporal Arteritis |
0.7% |
| Atrial Fibrillation |
0.6% |
| Bipolar Disorder |
0.6% |
| Bone Density Decreased |
0.6% |
| Hypothyroidism |
0.6% |
|
| Femur Fracture |
18.0% |
| Osteosclerosis |
9.4% |
| Osteonecrosis Of Jaw |
8.6% |
| Osteonecrosis |
6.9% |
| Myalgia |
4.7% |
| Pain In Extremity |
4.7% |
| Stress Fracture |
4.7% |
| Oesophageal Carcinoma |
4.3% |
| Rectal Haemorrhage |
3.9% |
| Vision Blurred |
3.9% |
| Atrial Fibrillation |
3.4% |
| Bone Disorder |
3.4% |
| Pain |
3.4% |
| Toxicity To Various Agents |
3.4% |
| Weight Decreased |
3.4% |
| Malaise |
3.0% |
| Pain In Jaw |
3.0% |
| Oesophageal Ulcer |
2.6% |
| Osteomyelitis |
2.6% |
| Pathological Fracture |
2.6% |
|
| Secondary |
| Osteoporosis |
17.8% |
| Drug Use For Unknown Indication |
16.7% |
| Product Used For Unknown Indication |
10.7% |
| Rheumatoid Arthritis |
8.9% |
| Migraine |
7.8% |
| Osteoarthritis |
5.1% |
| Asthma |
4.2% |
| Systemic Lupus Erythematosus |
4.2% |
| Hypertension |
3.5% |
| Depression |
2.9% |
| Osteoporosis Prophylaxis |
2.9% |
| Spinal Column Stenosis |
2.4% |
| Drug Exposure During Pregnancy |
1.8% |
| Deep Vein Thrombosis |
1.7% |
| Epilepsy |
1.7% |
| Osteoporosis Postmenopausal |
1.7% |
| Pemphigus |
1.7% |
| Constipation |
1.5% |
| Hypothyroidism |
1.5% |
| Psoriatic Arthropathy |
1.4% |
|
| Dyspnoea |
8.5% |
| Teratogenicity |
8.5% |
| Femur Fracture |
7.4% |
| Cerebrovascular Accident |
6.4% |
| Pain |
6.4% |
| Hypotonia |
5.3% |
| Osteonecrosis Of Jaw |
5.3% |
| Pain In Extremity |
5.3% |
| Tubulointerstitial Nephritis |
5.3% |
| Vomiting |
5.3% |
| Rectal Haemorrhage |
4.3% |
| Trismus |
4.3% |
| Vision Blurred |
4.3% |
| Withdrawal Syndrome |
4.3% |
| Fatigue |
3.2% |
| Melaena |
3.2% |
| Osteonecrosis |
3.2% |
| Pathological Fracture |
3.2% |
| Somnolence |
3.2% |
| Varices Oesophageal |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.2% |
| Drug Use For Unknown Indication |
18.1% |
| Rheumatoid Arthritis |
15.1% |
| Osteoporosis |
8.6% |
| Hypertension |
4.3% |
| Pain |
2.3% |
| Prophylaxis |
2.1% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Depression |
1.6% |
| Asthma |
1.4% |
| Osteoarthritis |
1.3% |
| Atrial Fibrillation |
1.2% |
| Diabetes Mellitus |
1.0% |
| Systemic Lupus Erythematosus |
0.8% |
| Neuralgia |
0.8% |
| Breast Cancer |
0.8% |
| Hypercholesterolaemia |
0.7% |
| Back Pain |
0.7% |
| Osteopenia |
0.7% |
| Schizophrenia |
0.6% |
|
| Vomiting |
13.9% |
| Malaise |
6.4% |
| Death |
5.7% |
| Nausea |
5.4% |
| Renal Failure Acute |
5.2% |
| Pneumonia |
5.0% |
| Pulmonary Embolism |
5.0% |
| Urinary Tract Infection |
5.0% |
| Sepsis |
4.7% |
| Thrombocytopenia |
4.5% |
| Cerebrovascular Accident |
4.2% |
| Pancytopenia |
4.2% |
| Syncope |
4.2% |
| Dyspnoea |
4.0% |
| Pulmonary Fibrosis |
4.0% |
| Renal Impairment |
4.0% |
| Rheumatoid Arthritis |
4.0% |
| Treatment Failure |
3.7% |
| Visual Impairment |
3.7% |
| Drug Interaction |
3.5% |
|
| Interacting |
| Osteoporosis |
45.5% |
| Dementia |
18.2% |
| Hypertension |
18.2% |
| Breast Cancer |
9.1% |
| Osteoporosis Prophylaxis |
9.1% |
|
| Dehydration |
33.3% |
| General Physical Health Deterioration |
33.3% |
| Migraine |
33.3% |
|
